Multiple Sclerosis Clinical Trials in Kansas City, Kansas

5 studies are recruiting for multiple sclerosis in Kansas City, Kansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

   This phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer that has spread from …

   Stage

   Phase 1

   Ages

   18 and older

   Site

   University of Kansas Cancer Center, Kansas City, Kansas

   Locations

   52 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT03816345 on ClinicalTrials.gov

2. Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis

   The incidence of insomnia is estimated to be as high as 90% in individuals with MS due to insomnia being underdiagnosed. Sleep disturbances in people with MS have been associated with reduced cognitive performance, physical function, psychological well-being, quality of life, and occupational funct…

   Stage

   Phase 2

   Ages

   18 to 65

   Site

   University of Kansas Medical Center, Kansas City, Kansas

   Run by

   University of Kansas Medical Center

   See if you can join NCT06428006 on ClinicalTrials.gov

3. Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

   The goal of this clinical trial is to treat male and female participants with two types of Multiple Sclerosis (MS) called primary progressive or secondary progressive MS. The main questions the trial aims to answer are the following: * Is TRX319 safe when administered to patients with progressive f…

   Stage

   Phase 1

   Ages

   18 to 65

   Site

   University of Kansas Medical Center, Kansas City, Kansas

   Locations

   2 in total

   Run by

   Tr1X, Inc.

   See if you can join NCT07477639 on ClinicalTrials.gov

4. Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue, and Promote Neuroprotection

   The objective of this RCT is to assess the efficacy of one-on-one telehealth CBT-I (tCBT-I) compared to web-based CBT-I (wCBT-I) and treatment as usual (TAU) to improve sleep outcomes (Aim 1), fatigue and quality of life (Aim 2), and promote neuroprotection (Exploratory Aim 3), and to explore the c…

   Stage

   Phase 2

   Ages

   18 to 65

   Site

   University of Kansas Medical Center- Sleep, Health and Wellness Laboratory, Kansas City, Kansas

   Run by

   University of Kansas Medical Center

   See if you can join NCT06434571 on ClinicalTrials.gov

5. Dry Needling in Multiple Sclerosis

   The investigators are doing this study to see if a treatment called dry needling improves muscle spasticity (muscle tightness) in people who have Multiple Sclerosis. Dry needling involves using tiny needles, like those in acupuncture, to target some muscles, like calf muscles. It differs from tradi…

   Stage

   Not phased

   Ages

   18 to 64

   Site

   Mobility and Falls Lab, Kansas City, Kansas

   Run by

   University of Kansas Medical Center

   See if you can join NCT06394310 on ClinicalTrials.gov